Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

adeno-associated

adeno-associated is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 6
News articles 0
Drug details — adeno-associated
Class
—
Route
—
Patents
20
Programs
6
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

adeno-associated is an FDA-listed pharmaceutical active ingredient.

Key facts

INN adeno-associated

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. CERE-110: Adeno-Associated Virus injection Surgery Phase 2 · SANGAMO THERAPEUTICS · Alzheimer's Disease
  2. CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) Phase 2 · SANGAMO THERAPEUTICS · Idiopathic Parkinson's Disease
  3. CERE-120: Adeno-Associated Virus Delivery of Neurturin Phase 2 · SANGAMO THERAPEUTICS · Idiopathic Parkinson's Disease
  4. ESTEVE-SANF-201 Phase 2 · Esteve Pharmaceuticals · Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)
  5. CERE-110: Adeno-Associated Virus Delivery of NGF Phase 1 · SANGAMO THERAPEUTICS · Alzheimer's Disease
  6. Recombinant adeno-associated virus administration Phase 1 · Kunming Hope of · Menkes Syndrome

Related patents

Browse patents

  1. US 12246047

    Adeno-associated virus purification methods

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12239692

    Adeno-associated virus factor VIII vectors

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12104165

    Adeno-associated virus with engineered capsid

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12031147

    Adeno-associated virus virions with variant capsids and methods of use thereof

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11981912

    Adeno associated virus vectors for the treatment of hunter disease

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11840704

    Adeno-associated virus variant capsids and methods of use thereof

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11821008

    Liver targeting adeno-associated viral vectors

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11761003

    Adeno-associated virus for activating RNA-NEAT1 over-expression and applications thereof

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11680249

    Adeno-associated virus capsid variants and methods of use thereof

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11584780

    Adeno-associated virus capsid proteins

    Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11565000

    Adeno-associated virus virions with variant capsid and methods of use thereof

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11554180

    Adeno-associated virus virions with variant capsid and methods of use thereof

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11419949

    Adeno-associated virus variant capsids and methods of use thereof

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11406690

    Adeno-associated virus factor VIII vectors

    Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11364308

    Adeno-associated virus variant capsids and methods of use thereof

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11332727

    Method for reducing an immune response by administering an immune evading adeno-associated AAV8 or AAVDJ viral vector

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11236360

    Adeno-associated viruses engineered for selectable tropism

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11236402

    Adeno-associated virus virions with variant capsid

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11179477

    Method of using adeno-associated virus with variant capsid

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is adeno-associated?

adeno-associated is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.